Stocktwits19h agobearish
NVO Stock Drops 6% Despite Raised Guidance As Investors Worry About Injectable GLP-1 Sales FutureNovo now expects underlying sales and operating profit in the range of 0% to –6% for the year.
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Novo now expects underlying sales and operating profit in the range of 0% to –6% for the year.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.